Diagnostica Stago Inc - Product Pipeline Analysis, 2018 Update

Diagnostica Stago Inc - Product Pipeline Analysis, 2018 Update


  • Products Id :- GDME1012PD
  • |
  • Pages: 36
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Diagnostica Stago Inc (Stago), a subsidiary of Diagnostica Stago SAS, is a medical device company that develops and distributes in-vitro diagnostic products. The company develops coagulation automation systems. It provides products such as hemostasis analyzers, viscosity based detection systems, reagents and research products. Stago's research and reagent products includes venoms, activators, purified proteins, coagulation factors, inhibitors, chromogenic substrates, lupus inhibitors, heparin anti-xa assays, coagulation inhibitors, fibrin and fibrinogen degradation products, among others. The company offers various customer services such as proficiency testing, field technical support, education and customer training. It also offers hemostasis proficiency testing program and peer group program. The company operates in the US and Canada. Stago is headquartered in Parsippany, New Jersey, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Diagnostica Stago Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Diagnostica Stago Inc Company Overview 5

Diagnostica Stago Inc Company Snapshot 5

Diagnostica Stago Inc Pipeline Products and Ongoing Clinical Trials Overview 5

Diagnostica Stago Inc-Pipeline Analysis Overview 7

Diagnostica Stago Inc-Key Facts 7

Diagnostica Stago Inc-Major Products and Services 8

Diagnostica Stago Inc Pipeline Products by Development Stage 9

Diagnostica Stago Inc Pipeline Products Overview 11

Calibrated Automated Thrombogram-Thrombin Assay 11

Calibrated Automated Thrombogram-Thrombin Assay Product Overview 11

STA Compact Max-Apixaban Calibrators And Controls 12

STA Compact Max-Apixaban Calibrators And Controls Product Overview 12

STA Compact Max-Dabigatran Calibrator And Control 13

STA Compact Max-Dabigatran Calibrator And Control Product Overview 13

STA Compact Max-Edoxaban Calibrator And Control 14

STA Compact Max-Edoxaban Calibrator And Control Product Overview 14

STA Compact Max-NeoPTimal ISI 15

STA Compact Max-NeoPTimal ISI Product Overview 15

STA Compact Max-Ristocetin Cofactor Assay 16

STA Compact Max-Ristocetin Cofactor Assay Product Overview 16

STA Compact Max-Rivaroxaban Calibrators And Controls For Anti-Xa 17

STA Compact Max-Rivaroxaban Calibrators And Controls For Anti-Xa Product Overview 17

STA-R Evolution Expert-Automated Ecarin Chromogenic Assay 18

STA-R Evolution Expert-Automated Ecarin Chromogenic Assay Product Overview 18

STA-R Evolution Expert-Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa 19

STA-R Evolution Expert-Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa Product Overview 19

STA-R Evolution Plus-Automated Ecarin Chromogenic Assay 20

STA-R Evolution Plus-Automated Ecarin Chromogenic Assay Product Overview 20

STA-R Evolution Plus-Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa 21

STA-R Evolution Plus-Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa Product Overview 21

STA-R Max-Apixaban Calibrators And Controls 22

STA-R Max-Apixaban Calibrators And Controls Product Overview 22

STA-R Max-Dabigatran Calibrator And Control 23

STA-R Max-Dabigatran Calibrator And Control Product Overview 23

STA-R Max-Edoxaban Calibrator And Control 24

STA-R Max-Edoxaban Calibrator And Control Product Overview 24

STA-R Max-NeoPTimal ISI 25

STA-R Max-NeoPTimal ISI Product Overview 25

STA-R Max-Ristocetin Cofactor Assay 26

STA-R Max-Ristocetin Cofactor Assay Product Overview 26

STA-R Max-Rivaroxaban Calibrators And Controls For Anti-Xa 27

STA-R Max-Rivaroxaban Calibrators And Controls For Anti-Xa Product Overview 27

Diagnostica Stago Inc-Key Competitors 28

Diagnostica Stago Inc-Key Employees 29

Diagnostica Stago Inc-Locations And Subsidiaries 30

Head Office 30

Other Locations & Subsidiaries 30

Recent Developments 31

Diagnostica Stago Inc, Recent Developments 31

Sep 16, 2014: Stago's D-Dimer test, 1st assay to meet the new CLSI H59-A standards for exclusion of PE 31

Aug 18, 2009: Diagnostica Stago Opens New Training Center 31

May 04, 2009: Instrumentation Laboratory Wins Patent Infringement And Unfair Competition Trial Against Diagnostica Stago Relating To Reagents For Hemostasis Diagnostics 31

Appendix 33

Methodology 33

About GlobalData 36

Contact Us 36

Disclaimer 36

List of Figures

Diagnostica Stago Inc Pipeline Products by Equipment Type 6

Diagnostica Stago Inc Pipeline Products by Development Stage 9

List of Tables

Diagnostica Stago Inc Pipeline Products and Ongoing Clinical Trials Overview 5

Diagnostica Stago Inc Pipeline Products by Equipment Type 6

Diagnostica Stago Inc Pipeline Products by Indication 6

Diagnostica Stago Inc, Key Facts 7

Diagnostica Stago Inc, Major Products and Services 8

Diagnostica Stago Inc Number of Pipeline Products by Development Stage 9

Diagnostica Stago Inc Pipeline Products Summary by Development Stage 10

Calibrated Automated Thrombogram-Thrombin Assay-Product Status 11

Calibrated Automated Thrombogram-Thrombin Assay-Product Description 11

STA Compact Max-Apixaban Calibrators And Controls-Product Status 12

STA Compact Max-Apixaban Calibrators And Controls-Product Description 12

STA Compact Max-Dabigatran Calibrator And Control-Product Status 13

STA Compact Max-Dabigatran Calibrator And Control-Product Description 13

STA Compact Max-Edoxaban Calibrator And Control-Product Status 14

STA Compact Max-Edoxaban Calibrator And Control-Product Description 14

STA Compact Max-NeoPTimal ISI-Product Status 15

STA Compact Max-NeoPTimal ISI-Product Description 15

STA Compact Max-Ristocetin Cofactor Assay-Product Status 16

STA Compact Max-Ristocetin Cofactor Assay-Product Description 16

STA Compact Max-Rivaroxaban Calibrators And Controls For Anti-Xa-Product Status 17

STA Compact Max-Rivaroxaban Calibrators And Controls For Anti-Xa-Product Description 17

STA-R Evolution Expert-Automated Ecarin Chromogenic Assay-Product Status 18

STA-R Evolution Expert-Automated Ecarin Chromogenic Assay-Product Description 18

STA-R Evolution Expert-Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa-Product Status 19

STA-R Evolution Expert-Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa-Product Description 19

STA-R Evolution Plus-Automated Ecarin Chromogenic Assay-Product Status 20

STA-R Evolution Plus-Automated Ecarin Chromogenic Assay-Product Description 20

STA-R Evolution Plus-Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa-Product Status 21

STA-R Evolution Plus-Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa-Product Description 21

STA-R Max-Apixaban Calibrators And Controls-Product Status 22

STA-R Max-Apixaban Calibrators And Controls-Product Description 22

STA-R Max-Dabigatran Calibrator And Control-Product Status 23

STA-R Max-Dabigatran Calibrator And Control-Product Description 23

STA-R Max-Edoxaban Calibrator And Control-Product Status 24

STA-R Max-Edoxaban Calibrator And Control-Product Description 24

STA-R Max-NeoPTimal ISI-Product Status 25

STA-R Max-NeoPTimal ISI-Product Description 25

STA-R Max-Ristocetin Cofactor Assay-Product Status 26

STA-R Max-Ristocetin Cofactor Assay-Product Description 26

STA-R Max-Rivaroxaban Calibrators And Controls For Anti-Xa-Product Status 27

STA-R Max-Rivaroxaban Calibrators And Controls For Anti-Xa-Product Description 27

Diagnostica Stago Inc, Key Employees 29

Diagnostica Stago Inc, Other Locations 30

Glossary 35

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

BioMed Diagnostics Inc

Helena Laboratories Corp

Alfa Wassermann Diagnostic Technologies, LLC

Diagnostica Stago Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license
Single User License
USD 750 INR 52500
Site License
USD 1500 INR 105000
Corporate User License
USD 2250 INR 157500

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com